PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
25-Jun-2025 Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation Sanofi
25-Jun-2025 Nipocalimab showed greater sustained disease control versus approved FcRn blockers for generalised myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC) Janssen-Cilag
25-Jun-2025 Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test Mainz BioMed N.V.
25-Jun-2025 The Newest Issue of Chairside(R) Magazine Reveals Insights Into the Present and Future of Dentistry ACCESS Newswire
25-Jun-2025 Xcell Biosciences Announces Joint Research Collaboration with Thermo Fisher Scientific to Advance the Next Generation of Cell Therapies Xcell, Thermo Fisher Scientific
25-Jun-2025 Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin Fortrea
25-Jun-2025 Bispecific T-cell Engagers (BiTEs) Market to Reach $5.45 Billion by 2025, Driven by Innovation in Cancer Immunotherapy globenewswireonlione
25-Jun-2025 Evaluate Releases Updated Pharmaceutical Market Forecasts in Annual World Preview Report Evaluate
25-Jun-2025 ARTIFICIAL INTELLIGENCE HELPS TO DETECT DANGEROUS COLON POLYPS University of Health Sciences
25-Jun-2025 Birmingham researchers work on revolutionary approach to prevent hay fever Birmingham Biotech LTD
25-Jun-2025 Brainomix and 3DR Labs Partner to Advance Stroke Care in the US Through Clinically Validated AI Imaging Solution Brainomix
25-Jun-2025 Exousia Pro Files Reg A. ACCESS Newswire
25-Jun-2025 The 31 Most Promising Healthcare RCM Startups and Scale-Ups of 2025: Black Book Research Announces Rankings Evaluated by Comprehensive Qualitative KPIs ACCESS Newswire
25-Jun-2025 Teva leads call to secure Europe’s access to critical medicines and protect health sovereignty Four Agency
25-Jun-2025 iTolerance, Inc. Appoints Former FDA Senior Executive Wayne Pines to the Board of Directors ACCESS Newswire
25-Jun-2025 Oxeltis and academic partners receive grant funding worth nearly €800,000 to develop antiviral for Bunyaviricetes Andrew Lloyd Associates
25-Jun-2025 Revolutionizing Clinical Research: Evolution Summit 2025 to Bring Together Industry Pioneers in Montreux, Switzerland Marcus Evans
25-Jun-2025 Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position ACCESS Newswire
25-Jun-2025 US Med-Equip Supports Hospitals With Bariatric Breakthroughs as Obesity Rates Climb Nationwide ACCESS Newswire
25-Jun-2025 Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs ACCESS Newswire